AU604249B2 - Macrocyclic compounds - Google Patents

Macrocyclic compounds

Info

Publication number
AU604249B2
AU604249B2 AU76217/87A AU7621787A AU604249B2 AU 604249 B2 AU604249 B2 AU 604249B2 AU 76217/87 A AU76217/87 A AU 76217/87A AU 7621787 A AU7621787 A AU 7621787A AU 604249 B2 AU604249 B2 AU 604249B2
Authority
AU
Australia
Prior art keywords
carbon atoms
groups
group
chain
straight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU76217/87A
Other versions
AU604249C (en
AU7621787A (en
Inventor
Heinz Dr. Gries
Bernd Dr. Raduchel
Ulrich Dr. Speck
Hans-Joachim Dr. Weinmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of AU7621787A publication Critical patent/AU7621787A/en
Publication of AU604249B2 publication Critical patent/AU604249B2/en
Application granted granted Critical
Publication of AU604249C publication Critical patent/AU604249C/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D273/00Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005Compounds without a metal-carbon linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/003Compounds containing elements of Groups 3 or 13 of the Periodic Table without C-Metal linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Polyethers (AREA)
  • Hydrogenated Pyridines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Compounds of the general formula I <IMAGE> in which Y is a nitrogen or phosphorus atom, A<1> and A<2> are identical or different and are each a straight-chain or branched alkylene group having 2 to 6 carbon atoms, U<1>, U<2>, U<3>, U<4> are identical or different and are each a direct bond or a straight-chain or branched alkylene group having 1 to 6 carbon atoms, D<1>, D<2>, D<3>, D<4> are identical or different and are each an oxygen or sulphur atom, an alkylene group having 1 to 6 carbon atoms or a group N-R<7> where R<7> has the meaning of a hydrogen atom, a straight-chain or branched alkylene chain having 1 to 4 carbon atoms, which carries a COOR<1> group at the end, in which R<1> represents a hydrogen atom or a metal ion equivalent, D<5> has the meaning given for D<1>, D<2>, D<3> and D<4> and the group <IMAGE> where R<5> has the meaning of a hydrogen atom or of a straight-chain or branched, saturated or unsaturated C1-C20-alkylene group which may contain imino, phenyleneoxy, phenyleneimino, amide, ester groups, oxygen, sulphur and/or nitrogen atoms and may be substituted by hydroxyl, mercapto, imino and/or amino groups and has either a functional group or bound via this group a macromolecule B at the end, s and t are integers from 0 to 5, R<2> is hydrogen, a linear or branched, saturated or unsaturated, alkyl, acyl or acylalkyl group of 1 to 16 carbon atoms which is unsubstituted or substitute by one or more hydroxyl or lower alkoxy groups, or is -CH2-X-V where X has the meaning of carbonyl, of a straight-chain or branched alkylene group having 0 to 10 carbon atoms, which is unsubstituted or substituted by one or more hydroxyl or lower alkoxy groups, or of a straight &tilde& chain or branched alkylene group having 2 to 23 carbon atoms which is interrupted by oxygen atoms, V has the meaning <IMAGE> or -COOR<6> in which R<3> and R<4>, independently of one another, are hydrogen, a linear o branched alkyl group having 1 to 16 carbon atoms which is unsubstituted or substituted by one or more hydroxyl or lower alkoxy groups, or R<3> and R<4> together with the nitrogen atom represent a saturated 5- or 6-membered ring which may contain a further hetero atom and R<6> represents hydrogen or a saturated, unsaturated, straight-chain or branched or cyclic hydrocarbon radical having up to 16 carbon atoms or represents an aryl or aralkyl group, or R<2> or R<3> denotes a second macrocycle of the formula I' <IMAGE> which is bound via an alkylene chain (K) containing 2 to 20 carbon atoms, which, if desired carries carbonyl groups at the ends and, if desired, is interrupted by one or more oxygen atoms or R<1>-carboxymethylimino groups or substituted by one or more hydroxyl, lower alkoxy or carboxy-lower alkyl groups, which macrocycle can have a structure which is different from that of the parent structure, or R<2> denotes B or CH2-COB, with the proviso that if Rz represents B or CH2-COB, R<5> denotes a hydrogen atom, that at least two COORi groups are present in the molecule and that two hetero atoms of the macrocycle are each bound to at least two carbon atoms via an alkylene group and functional groups present in the molecule are, if desired conjugated with macromolecules and, if desired free carboxyl groups have been converted with organic or inorganic bases or amino acids and basic groups with inorganic or organic acids to the salts.
AU76217/87A 1986-07-28 1987-07-27 Macrocyclic compounds Expired AU604249C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3625417 1986-07-28
DE3625417A DE3625417C2 (en) 1986-07-28 1986-07-28 Tetraazacyclododecane derivatives

Publications (3)

Publication Number Publication Date
AU7621787A AU7621787A (en) 1988-02-04
AU604249B2 true AU604249B2 (en) 1990-12-13
AU604249C AU604249C (en) 1993-09-16

Family

ID=

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU620841B2 (en) * 1987-12-24 1992-02-27 Bracco International B.V. Macrocyclic chelating agents and chelates thereof
AU625529B2 (en) * 1989-12-22 1992-07-16 E.R. Squibb & Sons, Inc. 10-(2'-hydroxy-3'-alkoxy-1,4,7-triscarboxymethyl-1,4,7,10- tetraazacyclododecanes
AU634167B2 (en) * 1988-06-24 1993-02-18 Dow Chemical Company, The Macrocyclic bifunctional chelants, complexes thereof and their antibody conjugates
AU656304B2 (en) * 1989-04-07 1995-02-02 Salutar, Inc. Chelants
AU658566B2 (en) * 1986-03-21 1995-04-27 Hybritech Incorporated Improvements in or relating to methods for providing internal references for use in analyte-receptor assays
US10793532B2 (en) 2016-09-27 2020-10-06 Bayer Pharma Aktiengesellschaft Method for producing the crystalline form of modification a of calcobutrol

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU658566B2 (en) * 1986-03-21 1995-04-27 Hybritech Incorporated Improvements in or relating to methods for providing internal references for use in analyte-receptor assays
AU620841B2 (en) * 1987-12-24 1992-02-27 Bracco International B.V. Macrocyclic chelating agents and chelates thereof
AU634167B2 (en) * 1988-06-24 1993-02-18 Dow Chemical Company, The Macrocyclic bifunctional chelants, complexes thereof and their antibody conjugates
AU656304B2 (en) * 1989-04-07 1995-02-02 Salutar, Inc. Chelants
AU625529B2 (en) * 1989-12-22 1992-07-16 E.R. Squibb & Sons, Inc. 10-(2'-hydroxy-3'-alkoxy-1,4,7-triscarboxymethyl-1,4,7,10- tetraazacyclododecanes
US10793532B2 (en) 2016-09-27 2020-10-06 Bayer Pharma Aktiengesellschaft Method for producing the crystalline form of modification a of calcobutrol
US11390592B2 (en) 2016-09-27 2022-07-19 Bayer Pharma Aktiengesellschaft Method for producing the crystalline form of modification a of calcobutrol

Also Published As

Publication number Publication date
NZ221225A (en) 1990-09-26
DE3781620D1 (en) 1992-10-15
ATE80391T1 (en) 1992-09-15
DK393387A (en) 1988-01-29
DE3625417C2 (en) 1998-10-08
IE872038L (en) 1988-01-28
NO174048B (en) 1993-11-29
DK171574B1 (en) 1997-01-20
DE3625417A1 (en) 1988-02-11
AU7621787A (en) 1988-02-04
ZA875561B (en) 1989-03-29
CA1341176C (en) 2001-01-30
NO873132D0 (en) 1987-07-27
PT85410A (en) 1987-08-01
GR3005808T3 (en) 1993-06-07
PT85410B (en) 1990-06-29
EP0255471A1 (en) 1988-02-03
JPH0753720B2 (en) 1995-06-07
EP0255471B1 (en) 1992-09-09
NO174048C (en) 1994-03-09
DK393387D0 (en) 1987-07-28
ES2052599T3 (en) 1994-07-16
JPS6341468A (en) 1988-02-22
NO873132L (en) 1988-01-29
IE60677B1 (en) 1994-08-10

Similar Documents

Publication Publication Date Title
ZA875561B (en) Macrocyclic compounds
GR3005807T3 (en)
KR910007704A (en) Fibrinogen receptor antagonist
AU589501B2 (en) Fuel composition
DE59402226D1 (en) Use of organofunctionally modified polysiloxanes for defoaming diesel fuel
EP0250358A3 (en) Novel complex compounds
ES8800321A1 (en) Additive for heated bitumen.
EP0341925A3 (en) An inorganic filler containing polyolefin composition
DE69203551D1 (en) Biodegradable copolyester of 4-hydroxyproline and pharmaceutical composition containing it.
BR8805623A (en) COMPOSITION AND ADDITIVE CONCENTRATE
DE3772685D1 (en) USE OF RARE EARTH MIXTURES TO STABILIZE FUELS FOR DIESEL ENGINES.
DE3686486D1 (en) COMPOSITIONS, CONCENTRATES, LUBRICANT PREPARATIONS, FUEL PREPARATION AND METHOD FOR IMPROVING THE FUEL SAVING OF COMBUSTION ENGINES.
ATE38675T1 (en) PHOSPHATE ESTER DERIVATIVES AND THEIR USE AS AN ANTI-CANCER AGENT.
FR2616663B1 (en) NOVEL NITROGEN POLYCYCLIC STRUCTURE TRIPEPTIDES, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
KR860002443A (en) Method for preparing anthracene derivative
EP0339088A4 (en) Improved traction fuid.
KR840001154A (en) Method for preparing 1,2-dithiol-3-ylidene ammonium derivative
KR860007222A (en) Method for preparing benzo [a] phenazine derivative
ES2012763B3 (en) WELDING COMPOSITIONS.
KR890010089A (en) Curable Resin Composition